Pyrimethamine tablets

Oral 500 mg sulfadoxine plus 25 mg pyrimethamine tablets Suramin ... 

Nebulized pentamidine at the dosage of 300 mg every two weeks should be used in patients with a CD4-I- count less than 100 mm if systemic therapy cannot be tolerated. Sulfadoxine/pyrimethamine (Fansidar), one tablet given once or twice a week, is useful in patients in whom compliance is considered to be a problem. However, it has been associated with hepatotoxicity, Stevens-Johnson syndrome and toxic epidermal necrolysis. 

Pyrimethamine 25 mg + suifadoxine 500 mg (MALARPRiM) Once a week 3 tablets single dose... 

Isospora belli Trimethoprim-sulfamethoxazole, one double-strength tablet 4 times daily for 10 days, then twice daily for 21 days Pyrimethamine, 75 mg daily for 14 days... 

Oral 26.3 mg (equivalent to 15 mg base) tablet Pyrimethamine (Daraprim)... 

A quinine satf 600 mg 8-hourly by mouth for 7 days followed by pyrimethamine plus sulfadoxine (Fansidar) 3 tablets as a single dose. Where there is resistance to Fansidar, doxycycline 200 mg, should be given after the course of quinine daily for at least 7 days. This additional therapy is necessary as quinine alone tends to be associated with a higher rate of relapse. 

Pyrimethamine acts synergistically with suifadoxine (as Fansidar) to inhibit folic acid metabolism (see antifols, above) suifadoxine is excreted in the urine. The combination is chiefly used with quinine to treat acute attacks of malaria caused by susceptible strains of Plasmodium falciparum a single dose of pyrimethamine 75 mg plus suifadoxine 1.5 g (3 tablets) usually suffices. 

In a placebo-controlled study of chemoprophylaxis for malaria, 701 Tanzanian infants were assigned to intermittent pyrimethamine + sulfadoxine (under 5 kg, a quarter of a tablet 5-10 kg, half a tablet over 10 kg, one tablet each tablet contained pyrimethamine 25 mg plus sulfadoxine 500 mg) alongside routine childhood immunizations and iron supplementation at 2, 3, and 9 months of age (4). The combination was well tolerated, with no reported adverse events. Episodes of clinical malaria fell by 59% (95% Cl = 41, 72) and the incidence of severe anemia by 50% (95% Cl = 8, 73%) in the first year of life. Contrary to previous studies involving continuous prophylaxis in infants, there was no increase in the frequency of rebound episodes of malaria up to 18 months of age, suggesting that the development of malaria-specific immunity was unimpaired. Responses to vaccines were unaffected. 

In P. falciparum (chloroquine-resistant) infections, a dose of 750 mg mefloquine followed by 500 mg 12 hours later is recommended. The pediatric dose of mefloquine is 15 mg/kg (<45 kg) followed by 10 mg/kg 8 to 12 hours later.Intravenous quinidine gluconate followed by oral quinine should be administered for severe illness, as already indicated.A second drug needs to be administered in chloroquine-resistant P. falciparum, and this second drug should follow the oral quinidine regimen either a single dose of three tablets of pyrimethamine-sulfadoxine (Fansidar) on the last day of intravenous quinidine or clindamycin 900 mg three times daily for 3 to 5 days. An alternative oral treatment for chloroquine-resistant P falciparum infection in adults, especially in those with a history of seizures or psychiatric disorders, is the combination of atovaquone 250 mg and proguanil 100 mg (Malarone) (4 tablets daily... 

Pyrimethamine (Daraprim) 25-mg tablet Malaria (see pyrimethamine-sulfadoxime) Gl Abdominal pain, vomiting, glossitis Hemat. Megaloblastic anemia, hemolytic anemia Recommended that folinic acid 1-5 mg/day be concurrently administered can cause hemolysis in patients with GbPO deficiency 9, 24, 25... 

SULFADOXINE AND PYRIMETHAMINE (Fansidar tablets 500 mg sulfadoxine and 25 mg pyrimethamine)... 

Sample preparation Powder tablets, add 40 mg pyrimethamine, dissolve in 20 mL MeCN, add 40 mL mobile phase, filter (paper), wash filter with mobile phase, make up filtrate to 100 mL with mobile phase. Dilute a 5 mL aliquot to 50 mL with mobile phase, inject a 20 p.L aliquot. 

Pyrimethamine-sulfadoxine (fansidar). This combination is available for oral use only in tablets containing 25 mg pyrimethamine and 500 mg sulfadoxine. One dose is taken by mouth on the last day of quinine sulfate therapy Adults take 3 tablets children 5-10 kg, 0.5 tablet 11-14 kg, 0.75 tablet 15-20 kg, 1 tablet 21-30 kg, 1.5 tablets 31 0 kg, 2 tablets 41-50 kg, 2.5 tablets over 50 kg, 3 tablets. Owing to extensive drug resistance, pyrimethamine-sulfadoxine should be used as an adjunct treatment primarily in young children or women who are not able to tolerate clindamycin. 

A study in patients with AIDS found that zidovudine 250 mg four times daily did not adversely affeet the prevention of toxoplasma eneephalitis with pyrimethamine/sulfadoxine (Fansidar), one tablet twice weekly for up to 8 months. /w vitro and animal data have shown that the combination of zidovudine and pyrimethamine caused synergistic decreases in lymphocyte and neutrophil numbers. ... 

---